研发-话题@MedSci

#研发#

826篇内容 | 7115人围观

关注话题

话题活跃用户

#插入话题

插入图片

最新最热

[GetTopicListResponse(id=1300234, encodeId=9e19130023405, content=<a href='/topic/show?id=ed5ee332423' target=_blank style='color:#2F92EE;'>#研发#</a>, objectTitle=神州医疗牵头国家重点研发计划”基于人工智能的临床辅助决策支持新型服务模式解决方案”, objectType=article, longId=159416, objectId=6ea215941656, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=6ea215941656, replyNumber=0, likeNumber=80, createdTime=2019-02-04, rootId=0, userName=lqvr, userId=aea0290, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=6ea215941656, moduleTitle=神州医疗牵头国家重点研发计划”基于人工智能的临床辅助决策支持新型服务模式解决方案”, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=6ea215941656)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1300233, encodeId=13fd13002334d, content=<a href='/topic/show?id=ed5ee332423' target=_blank style='color:#2F92EE;'>#研发#</a>, objectTitle=中国“芯”读出耳聋遗传密码，博奥生物团队参与研发, objectType=article, longId=158962, objectId=0f7f158962b6, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=0f7f158962b6, replyNumber=0, likeNumber=54, createdTime=2019-01-28, rootId=0, userName=lqvr, userId=aea0290, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=0f7f158962b6, moduleTitle=中国“芯”读出耳聋遗传密码，博奥生物团队参与研发, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=0f7f158962b6)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1300232, encodeId=854f13002329b, content=<a href='/topic/show?id=ed5ee332423' target=_blank style='color:#2F92EE;'>#研发#</a>, objectTitle=Cell：抗病毒“新兵”打造人体**道防线新机制为抗艾药物研发提供新途径, objectType=article, longId=158896, objectId=a6ad15889681, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=a6ad15889681, replyNumber=0, likeNumber=62, createdTime=2019-01-27, rootId=0, userName=lqvr, userId=aea0290, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=a6ad15889681, moduleTitle=Cell：抗病毒“新兵”打造人体**道防线新机制为抗艾药物研发提供新途径, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=a6ad15889681)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1300231, encodeId=76251300231c2, content=<a href='/topic/show?id=ed5ee332423' target=_blank style='color:#2F92EE;'>#研发#</a>, objectTitle=安徽鼓励仿制药研发全国首仿有重奖, objectType=article, longId=158786, objectId=4353158e86e4, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=4353158e86e4, replyNumber=0, likeNumber=52, createdTime=2019-01-26, rootId=0, userName=lqvr, userId=aea0290, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=4353158e86e4, moduleTitle=安徽鼓励仿制药研发全国首仿有重奖, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=4353158e86e4)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1300230, encodeId=9a2a1300230c7, content=<a href='/topic/show?id=ed5ee332423' target=_blank style='color:#2F92EE;'>#研发#</a>, objectTitle=安徽鼓励仿制药研发全国首仿奖励200万元, objectType=article, longId=158777, objectId=d070158e7780, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=d070158e7780, replyNumber=0, likeNumber=105, createdTime=2019-01-26, rootId=0, userName=lqvr, userId=aea0290, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=d070158e7780, moduleTitle=安徽鼓励仿制药研发全国首仿奖励200万元, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=d070158e7780)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1300229, encodeId=de4513002293c, content=<a href='/topic/show?id=ed5ee332423' target=_blank style='color:#2F92EE;'>#研发#</a>, objectTitle=中国本土研发的抗癌疗法首次获FDA突破性疗法认定, objectType=article, longId=158423, objectId=b1a1158423d6, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=b1a1158423d6, replyNumber=0, likeNumber=108, createdTime=2019-01-20, rootId=0, userName=lqvr, userId=aea0290, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=b1a1158423d6, moduleTitle=中国本土研发的抗癌疗法首次获FDA突破性疗法认定, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=b1a1158423d6)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1300228, encodeId=75581300228bc, content=<a href='/topic/show?id=ed5ee332423' target=_blank style='color:#2F92EE;'>#研发#</a>, objectTitle=重视研发迈瑞医疗获“第十一届健康中国论坛-十大医疗器械”奖, objectType=article, longId=158068, objectId=27d715806828, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=27d715806828, replyNumber=0, likeNumber=50, createdTime=2019-01-16, rootId=0, userName=lqvr, userId=aea0290, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=27d715806828, moduleTitle=重视研发迈瑞医疗获“第十一届健康中国论坛-十大医疗器械”奖, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=27d715806828)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1300227, encodeId=f055130022e3d, content=<a href='/topic/show?id=ed5ee332423' target=_blank style='color:#2F92EE;'>#研发#</a>, objectTitle=J Med Chem:合肥研究院研发出针对急性髓性白血病FLT3-ITD突变选择性的第三代新型FLT3激酶抑制剂, objectType=article, longId=157734, objectId=5a8f15e7340d, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=5a8f15e7340d, replyNumber=0, likeNumber=55, createdTime=2019-01-11, rootId=0, userName=lqvr, userId=aea0290, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=5a8f15e7340d, moduleTitle=J Med Chem:合肥研究院研发出针对急性髓性白血病FLT3-ITD突变选择性的第三代新型FLT3激酶抑制剂, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=5a8f15e7340d)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1300226, encodeId=758913002261d, content=<a href='/topic/show?id=ed5ee332423' target=_blank style='color:#2F92EE;'>#研发#</a>, objectTitle=我国自主研发抗癌新药达伯舒获准上市，价格将低于同类进口药, objectType=article, longId=157612, objectId=611715e61263, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=611715e61263, replyNumber=0, likeNumber=61, createdTime=2019-01-10, rootId=0, userName=lqvr, userId=aea0290, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=611715e61263, moduleTitle=我国自主研发抗癌新药达伯舒获准上市，价格将低于同类进口药, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=611715e61263)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1300225, encodeId=059b1300225c2, content=<a href='/topic/show?id=ed5ee332423' target=_blank style='color:#2F92EE;'>#研发#</a>, objectTitle=J. Am. Chem. Soc：天然产物药物研发取得进展, objectType=article, longId=157367, objectId=d93e15e367bf, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=d93e15e367bf, replyNumber=0, likeNumber=87, createdTime=2019-01-07, rootId=0, userName=lqvr, userId=aea0290, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=d93e15e367bf, moduleTitle=J. Am. Chem. Soc：天然产物药物研发取得进展, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=d93e15e367bf)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1300224, encodeId=1ab513002246f, content=<a href='/topic/show?id=ed5ee332423' target=_blank style='color:#2F92EE;'>#研发#</a>, objectTitle=上海自贸区：医药研发企业的“靶向药”, objectType=article, longId=157303, objectId=0ebb15e3037c, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=0ebb15e3037c, replyNumber=0, likeNumber=65, createdTime=2019-01-06, rootId=0, userName=lqvr, userId=aea0290, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=0ebb15e3037c, moduleTitle=上海自贸区：医药研发企业的“靶向药”, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=0ebb15e3037c)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1300223, encodeId=d5ed13002234c, content=<a href='/topic/show?id=ed5ee332423' target=_blank style='color:#2F92EE;'>#研发#</a>, objectTitle=单抗类药物研发全景图, objectType=article, longId=157077, objectId=387015e0773b, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=387015e0773b, replyNumber=0, likeNumber=75, createdTime=2019-01-01, rootId=0, userName=lqvr, userId=aea0290, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=387015e0773b, moduleTitle=单抗类药物研发全景图, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=387015e0773b)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1300222, encodeId=a931130022259, content=<a href='/topic/show?id=ed5ee332423' target=_blank style='color:#2F92EE;'>#研发#</a>, objectTitle=邹德慧教授：Zanubrutinib在套细胞淋巴瘤（MCL）等多种B细胞淋巴瘤中应用前景广阔，成为我国自主研发药的重大里程碑, objectType=article, longId=156972, objectId=67fa1569e267, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=67fa1569e267, replyNumber=0, likeNumber=82, createdTime=2018-12-31, rootId=0, userName=lqvr, userId=aea0290, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=67fa1569e267, moduleTitle=邹德慧教授：Zanubrutinib在套细胞淋巴瘤（MCL）等多种B细胞淋巴瘤中应用前景广阔，成为我国自主研发药的重大里程碑, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=67fa1569e267)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1300221, encodeId=b5a81300221ab, content=<a href='/topic/show?id=ed5ee332423' target=_blank style='color:#2F92EE;'>#研发#</a>, objectTitle=我国自主研发PD-1单抗特瑞普利单抗获批上市, objectType=article, longId=156573, objectId=46071565e3c1, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=46071565e3c1, replyNumber=0, likeNumber=75, createdTime=2018-12-26, rootId=0, userName=lqvr, userId=aea0290, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=46071565e3c1, moduleTitle=我国自主研发PD-1单抗特瑞普利单抗获批上市, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=46071565e3c1)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1300220, encodeId=d3d21300220dc, content=<a href='/topic/show?id=ed5ee332423' target=_blank style='color:#2F92EE;'>#研发#</a>, objectTitle=药明巨诺研发中心在沪落成助推细胞免疫治疗纵深创新, objectType=article, longId=155710, objectId=ea78155e10f0, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=ea78155e10f0, replyNumber=0, likeNumber=64, createdTime=2018-12-14, rootId=0, userName=lqvr, userId=aea0290, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=ea78155e10f0, moduleTitle=药明巨诺研发中心在沪落成助推细胞免疫治疗纵深创新, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=ea78155e10f0)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1300219, encodeId=d1cb1300219ce, content=<a href='/topic/show?id=ed5ee332423' target=_blank style='color:#2F92EE;'>#研发#</a>, objectTitle=Nat Nanotechnol：研发纳米喷胶，有望抑制术后肿瘤复发, objectType=article, longId=155618, objectId=0fb115561896, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=0fb115561896, replyNumber=0, likeNumber=68, createdTime=2018-12-13, rootId=0, userName=lqvr, userId=aea0290, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=0fb115561896, moduleTitle=Nat Nanotechnol：研发纳米喷胶，有望抑制术后肿瘤复发, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=0fb115561896)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1300218, encodeId=4f8a1300218a8, content=<a href='/topic/show?id=ed5ee332423' target=_blank style='color:#2F92EE;'>#研发#</a>, objectTitle=Sci Transl Med：癌症疫苗研发理念重大变革！大部分肿瘤特异抗原来自非编码DNA, objectType=article, longId=155347, objectId=e73415534e3e, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=e73415534e3e, replyNumber=0, likeNumber=61, createdTime=2018-12-09, rootId=0, userName=lqvr, userId=aea0290, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=e73415534e3e, moduleTitle=Sci Transl Med：癌症疫苗研发理念重大变革！大部分肿瘤特异抗原来自非编码DNA, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=e73415534e3e)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1300217, encodeId=49ef130021e53, content=<a href='/topic/show?id=ed5ee332423' target=_blank style='color:#2F92EE;'>#研发#</a>, objectTitle=Applied Materials Today：可无缝修复“脆”软骨的强力组织粘合胶水研发成功, objectType=article, longId=155310, objectId=a4421553106b, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=a4421553106b, replyNumber=0, likeNumber=76, createdTime=2018-12-08, rootId=0, userName=lqvr, userId=aea0290, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=a4421553106b, moduleTitle=Applied Materials Today：可无缝修复“脆”软骨的强力组织粘合胶水研发成功, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=a4421553106b)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1300216, encodeId=e4aa130021617, content=<a href='/topic/show?id=ed5ee332423' target=_blank style='color:#2F92EE;'>#研发#</a>, objectTitle=惊呆！这种病的新药研发平均每成功1款就失败约37款, objectType=article, longId=155178, objectId=f95b1551e8b1, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=f95b1551e8b1, replyNumber=0, likeNumber=62, createdTime=2018-12-07, rootId=0, userName=lqvr, userId=aea0290, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=f95b1551e8b1, moduleTitle=惊呆！这种病的新药研发平均每成功1款就失败约37款, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=f95b1551e8b1)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1300215, encodeId=4b3c130021587, content=<a href='/topic/show?id=ed5ee332423' target=_blank style='color:#2F92EE;'>#研发#</a>, objectTitle=港科大与北京天坛医院研发治疗脑癌新药，最快2年后投入治疗, objectType=article, longId=155147, objectId=725415514e57, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=725415514e57, replyNumber=0, likeNumber=63, createdTime=2018-12-06, rootId=0, userName=lqvr, userId=aea0290, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=725415514e57, moduleTitle=港科大与北京天坛医院研发治疗脑癌新药，最快2年后投入治疗, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=725415514e57)], followStatus=false, userIsMember=false, type=1, lengthMark=0)] 梅斯话题小助手

研发

2020-05-29

lqvr (审核中...)

前往app查看评论内容

#研发#

神州医疗牵头国家重点研发计划”基于人工智能的临床辅助决策支持新型服务模式解决方案”

2019-02-04

lqvr (审核中...)

前往app查看评论内容

#研发#

中国“芯”读出耳聋遗传密码，博奥生物团队参与研发

2019-01-28

lqvr (审核中...)

前往app查看评论内容

#研发#

Cell：抗病毒“新兵”打造人体**道防线新机制为抗艾药物研发提供新途径

2019-01-27

lqvr (审核中...)

前往app查看评论内容

#研发#

安徽鼓励仿制药研发全国首仿有重奖

2019-01-26

lqvr (审核中...)

前往app查看评论内容

#研发#

安徽鼓励仿制药研发全国首仿奖励200万元

2019-01-26

lqvr (审核中...)

前往app查看评论内容

#研发#

中国本土研发的抗癌疗法首次获FDA突破性疗法认定

2019-01-20

lqvr (审核中...)

前往app查看评论内容

#研发#

重视研发迈瑞医疗获“第十一届健康中国论坛-十大医疗器械”奖

2019-01-16

lqvr (审核中...)

前往app查看评论内容

#研发#

J Med Chem:合肥研究院研发出针对急性髓性白血病FLT3-ITD突变选择性的第三代新型FLT3激酶抑制剂

2019-01-11

lqvr (审核中...)

前往app查看评论内容

#研发#

我国自主研发抗癌新药达伯舒获准上市，价格将低于同类进口药

2019-01-10

lqvr (审核中...)

前往app查看评论内容

#研发#

J. Am. Chem. Soc：天然产物药物研发取得进展

2019-01-07

lqvr (审核中...)

前往app查看评论内容

#研发#

上海自贸区：医药研发企业的“靶向药”

2019-01-06

lqvr (审核中...)

前往app查看评论内容

#研发#

单抗类药物研发全景图

2019-01-01

lqvr (审核中...)

前往app查看评论内容

#研发#

邹德慧教授：Zanubrutinib在套细胞淋巴瘤（MCL）等多种B细胞淋巴瘤中应用前景广阔，成为我国自主研发药的重大里程碑

2018-12-31

lqvr (审核中...)

前往app查看评论内容

#研发#

我国自主研发PD-1单抗特瑞普利单抗获批上市

2018-12-26

lqvr (审核中...)

前往app查看评论内容

#研发#

药明巨诺研发中心在沪落成助推细胞免疫治疗纵深创新

2018-12-14

lqvr (审核中...)

前往app查看评论内容

#研发#

Nat Nanotechnol：研发纳米喷胶，有望抑制术后肿瘤复发

2018-12-13

lqvr (审核中...)

前往app查看评论内容

#研发#

Sci Transl Med：癌症疫苗研发理念重大变革！大部分肿瘤特异抗原来自非编码DNA

2018-12-09

lqvr (审核中...)

前往app查看评论内容

#研发#

Applied Materials Today：可无缝修复“脆”软骨的强力组织粘合胶水研发成功

2018-12-08

lqvr (审核中...)

前往app查看评论内容

#研发#

惊呆！这种病的新药研发平均每成功1款就失败约37款

2018-12-07

lqvr (审核中...)

前往app查看评论内容

#研发#

港科大与北京天坛医院研发治疗脑癌新药，最快2年后投入治疗

2018-12-06

科室
- - 订阅+
  - 更多科室
工具
服务